Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EDDYF (EDDYD) just did a 1/8. I may have to short that ticker at $.16 My daughters agrees when she says "mommy why do you always say people love to lose money" I say because they do.
The POT delivery cars "Bud Cars" did not exist, they were photoshopped VW's. Google BUD cars and you only see 4 images of cars that did not exist except on the desktop of a graphics designer.
The pot delivery cars a while back, wonder what is going on now
Right on, Suissac. Mr. Chan's latest "venture" from this past February has produced zero pump since the announcement. No CEO in his right mind would offer $70 million for two distressed hot desert area hotels, and be convinced that they are good opportunities for "PUB-CO" action. Have not heard a word since the announcement. I'm sure you agree. Mr. Chan is a fraud, and he is bilking any shareholder who doesn't know what's going on. If it was a good deal, he would buy it for his LMK Corporation.
I have been following Sugarmade since 2018, and not one thing jimmy chan (all lowercase), has PR'd has come to pass. This guy should be shut down, and when I see him do any type of Pump and Dump from here on out, I'm reporting it immediately.
OK. If people know ALL the stocks they are buying into that none of the money goes to the company you think they would just HOLD off on buying. These stocks are a lotto play not an investment strategy. They play just to gamble and know full well they will never win. If they thought for one instance they would win on any given ticker they would invest $10,000 not just $100.
I already know that. Hence, my post.
I lost complete faith a couple of years ago in this stock. Changing business strategies, acquisitions and complicated partnerships with revenue and growth estimates that never materialize, If I have missed something and this has better prospects than i think please let me know ! GLTA
3cents, it's really not a tangled web, it's just 3 or 4 people running the scheme with Jimmy being the least paid. Hes just the patsy CEO who makes very little to issues shares to the debt investors. I posted this over on another ticker page, Maybe this will sink in the reality of it all.
There is no limit to the shares that can be issued to the float.
The company puts fake debt on the books.
Debt investors agree to pay $20,000 in debt for 100,000,000 restricted shares
As the shares are diluted to the float, the debt investors pay less and less for each 100,000,000. As the shares drop the float increases and the company CEO keeps the debt payments and does not use the money to help the company.
The debt investors file 3(a)10 to have those shares made free trading
The shares the debt investors now own that YOU are buying, are NOT owned by the company. You are giving you money to a private individual not associated with the company!!!!!!
The SHARES YOU ALL BUY, none of your money goes to the CEO or the company. You are buying shares that have no longer a link to the company.
That is why all these TICKERS drop to red red red.
As long as retail suckers keep buying these stocks thinking it’s going to the company to make their scheme plans work, they will keep having shares to sell.
As long as there is debt with no limit to shares, the float will rise and the stock will fall.
The company says they are going to expand but the money you all invested does not go to the company.
Can’t you all see that when these stinky pinky’s raise $50,000,000 or more you never see the money on their financials because the company did NOT get the money.
Am I the only one who sees this?
ALL YOU INVESTORS who are buying shares, the money is NOT GOING to the company! AND the CEO's are all in on the scheme.
Get it through your thick heads. GOOD LORD!
What a tangled web. Mr. Chan is in cahoots with all these thieves.
Sugar Rush, Inc Is This You ? Page #38 https://www.otcmarkets.com/otcapi/company/financial-report/366025/content
1 Entry into a Material Definitive Agreement.
The information set forth in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 13, 2023, Salona Global Medical Device Corporation (the "Company") exercised its right to terminate the employment of Luke Faulstick as the Company's President and Chief Executive Officer. Mr. Faulstick will continue as a member of the Company's Board of Directors.
On June 13, 2023, upon terminating Mr. Faulstick, the Company appointed Michael Seckler, 58, to the position of Interim Chief Executive Officer, effective immediately. From October 2022 through May 2023, Mr. Seckler served as Chief Operating Officer and from March 2020 through September 2022 served as Senior Vice President Operations of FerGene, a gene therapy company affiliated with Ferring International Center, SA , a Swiss multinational biopharmaceutical company ("Ferring"). From June 2017 through February 2020, Mr. Seckler was Vice President Global Marketing and Communications at Ferring.
In connection with Mr. Seckler's appointment as Interim Chief Executive Officer, he will be paid an annual salary of US$100,000 and variable compensation based on incentives of up to US$200,000 annually. Additionally, he has ?been granted options under the Company's Stock Option Plan to acquire an aggregate of 250,000 Common Shares of the Company, over a three-year period, vesting 1/3 per year for three years, at an ?exercise price of CAD$0.25 per share. The options and underlying Common Shares are ?subject to a four-month and one day hold period pursuant to the rules of the TSX Venture Exchange. In addition, Mr. Seckler will be eligible to participate in the benefit programs generally available to executive officers of the Company.
There are no arrangements or understandings between Mr. Seckler and any other persons pursuant to which he was selected as Interim Chief Executive Officer. There are also no family relationships between Mr. Seckler and any director or executive officer of the Company and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
On June 2, 2023, the Company terminated the employment of Joseph Martinez, but Mr. Martinez continues to be available to the Company on an hourly basis as a consultant pursuant to the terms of a consulting agreement, and on June 13, 2023 he ceased to hold the titles of Senior Vice President, Legal & Compliance, General Counsel and Secretary of the Company.
What I would have in mind is not all 5000 penny stocks but rather a rule specifically for biotech stocks, and perhaps energy innovation stocks that trade under $5.00. There are 84 million Americans who live with pain everyday due to disease, injury or old age. The best possible medical care requires new ideas and new drugs, procedures or devices.
My proposition is that biotech, since it serves our most important and urgent needs would be protected from legal financial corruption.If you bought a share you can sell that share anytime if you are small fry retail. Institutions, HF, and wealthy traders would have a holding period. They can not sell short until the PPS is over $5.00.
Companies would still be able to raise money by selling shares. The toxic convertible debt problem could be avoided it seems to me. Dilution is surely a problem for investors, but the secret collusive schemes to go naked short and then massively dilute could be controlled. When the share price is significantly higher because of a lack of deceptive collusive share selling schemes then the shares that get sold are more effective in raising the needed capital for the company. These are just my ideas. Tell me why I am wrong about this.
The bad actors who make so much money through the legal corruption might have a compassion for curing diseases or saving our planet from a climate disaster. They could still make their ill begotten money on the myriad companies that do things that don’t really matter much.
Thanks
Besao, quick reply.
1) How about you come back to me when they DO get FDA approval for the cancer cure and not FDA approval on the method of its delivery (Oral or by injection) I can get DA approval for a new way to dispense water from a bottle its that easy. Show me the FDA on the cancer cure or treatment then well talk about that.
2) The ONLY way debt shares are issued that is the ONLY way shares are diluted and drop in price is due to DEBT 3(a)10 rule that allows someone who pays debt to get what ever amount of shares they want so they can dilute them for less then the bid and add to the float killing the price.
Get rig of 3(1)10 so you cant get shares free traded when paying debt and the OTC will lose 5,000 or more tickers the next day. But the OTC charges $10,000 annually for each ticker so they would lose in revenue $50,000,000 annually and the 5,000 pump and dumps would lose about $100 BILLION annually combined in sucker stock buys from 100's of millions of sucker retailers.
With that much money on the line, Regulations will never change.
Thanks MallenNV for that court case. There is so much corruption from all sides except for the gullible long retail investor who places trust almost blindly.
If NWBO gets FDA approval to treat glioblastoma perhaps that would overcome the massive debt. The shorts are thinking that those are long odds and that they would be able to cover before that ever happens.
Do you see any reforms that could make the penny stock market more transparent and fair for the gullible and vulnerable retail investor?
Is short selling a necessary feature for efficient price discovery? Perhaps short selling should not be allowed for a security that is below a certain market cap. Stocks that are held long would be allowed to be sold, but no short selling or naked short selling. What harm would be done by doing this to protect small companies from abusive practices?
Toxic convertible debt could also be regulated to eliminate abusive practices similar to the usury laws that limit outrageous interest rates from being imposed.
Thanks
NWBO is a development stage company (Means they have and do nothing) they operate out of “YET AGAIN” an office suite.
They have 1 billion shares in the float and 1,700,000,000 authorized (For now). That means they have 700,000,000 to use on debt conversions.
5 ticker changes.
They have massive debt and no cash! With no cash they have no choice but to debt dilute, take the cash and blame others to divert shareholders from a class action. Although some have and are suing the company. Seems like your typical debt diluted scheme.
As per the SEC;
SEC Files Settled Action Against Biotechnology Company Related to Unremediated Material Weaknesses Spanning Twelve Years
ADMINISTRATIVE PROCEEDING
File No. 3-19582
October 10, 2019 - The Securities and Exchange Commission today filed a settled action against Northwest Biotherapeutics (NWBO) for failing to maintain internal control over financial reporting (ICFR) for twelve consecutive annual reporting periods. In each of its annual Form 10-K filings with the Commission over more than a decade, NWBO disclosed material weaknesses, many of which recurred year after year, with insufficient effort at remediation.
ALSO! $41 million in stock options to debt dump to investors.
A Northwest Biotherapeutics Inc. Investor sued members of its board in Delaware, claiming they gave themselves nearly $41 million in stock options in an “unprecedented and indefensible” effort to offset the dilutive effects of a financing transaction that caused them “absolutely no economic harm.”
The lawsuit, made public Wednesday, alleges a “gross abuse” of fiduciary power by the directors who engineered the “true-up” deal after issuing equity on terms that equally diluted every stockholder while increasing the company’s overall value. The board members and general counsel, who also participated in the true-up, had no right “to own a specific percentage ...
Andrews & Springer LLC announces that it has filed a class action lawsuit on behalf of Northwest Biotherapeutics, Inc. ("NWBO") and minority shareholders in the Delaware Court of Chancery - Case No. 11179. NWBO is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments without toxicities of the kind associated with chemotherapies.
The complaint alleges that NWBO's Board of Directors along with its CEO and Chairperson Linda Powers ("Powers") and entities under her control -- Toucan Capital Fund III, L.P., Toucan Partners LLC and Cognate Bioservices, Inc. ("Cognate") -- breached their fiduciary duties by causing the Company to convert some of Cognate's outstanding invoices and future invoices (for prior services provided to the Company) into NWBO equity at an unfair price at the expense of the Company and minority shareholders.
Paying off debt to convert to debt shares to sell cheap, that was a company action not the MM's.
Any of the news about this being the market makers fault may be true but the company set them up to debt dilute. I thing the company is just blaming others for actions they did to get sympathy from investors to prevent another class action while the company unloads more shares to get out before they ticker is deleted.
Its ALL ABOUT self enrichment nothing else. https://nwbio.com/Stipulation%20of%20Settlement.pdf
The problems that we discuss are being addressed directly in a court case filed by NorthWest Biotherapeutics NWBO. The troublesome issues are most pronounced in the small cap biotech arena. The following is a comment placed on the NWBO board where the harms are being addressed and the plaintiffs are attempting to have the corruption become specifically delineated.
“We all agree that spoofing of any company developing a life-saving treatment and the associated naked shorting which it facilitates is reprehensible in the extreme.
We all know that this results in a depressed share price (and hence the value of the company).
We all know that a Nobel Prize winning economists affirms that this is not a transient phenomenon but has long term effects on the share price.
In the submission by Cohen Millstein against Market Makers, Citadel and other hedge funds, the claim is made that:
The company believes that the market makers directly impacted the price of Northwest Biotherapeutics’ shares in the market .... causing Northwest Biotherapeutics to suffer significant losses as it sold millions of shares at artificially depressed prices and was slowed in bringing its encouraging drugs to market.
I would like to ask 2 questions:
1] Is there any actual evidence that spoofing or any form of shorting has ever resulted in a delay in obtaining regulatory licencing for a therapeutic, and specifically for DCVax-L?
2] If there is such evidence, can the delay to the licencing of DCVax-L be quantified?
If there is a quantifiable delay, I would hope that Ms. Posner of Cohen Millstein would provide Judge Gabriel Gorenstein with a fairly accurate assessment of how many patients in the USA died from GBM having been denied the possibility of curative treatment with DCVax-L because of the delay in its licencing consequent upon the illegal spoofing.
One would certainly hope that with such information, the case would go to trial so that the defendants could not buy their way out of being exposed for what they are and that this would allow Judge Gorenstein to make the punishment fit the crime.”
Thanks
Fair and efficient price discovery cannot happen with all of this MM collusion that we have discussed and analyzed. The individual retail investors need to let the regulatory agencies and congress know about their concerns.
Do you think there is anybody who is educated and articulate that is currently reaching out to convey the salient information to make changes that protect the integrity of investing with regard to penny stocks and those stocks trading under $5.00?
Ultimately, like you have said before, it is Congress that must make amendments to the laws.
Is there a limited wealth retail investor association?
Thanks.
Are the market makers largely incentivized to collude with each other most of the time or do they sometimes try to fool each other to make more money?
From what I know, if any broker, market maker or debt dilution schemer deflects from the norm and tries to fool another MM or broker, they will be cut off from the pump and dump money. If a market maker does fool anyone in the group, brokers will not buy debt shares from that market maker and the ones selling debt shares will not sell to those market makers essentially putting the MM out of business. Besides there is so much money to be made there is no reason for a MM to fool others to make money when there is enough money for everyone already.
What are the qualifications to become a market maker?
If you want to be a MM on the OTC (Under $5 stocks) you have to pay $1,000 for each ticker you want to make a market in. Plus you need capital like $100,000 and fill out forms with FINRA. I don’t think it’s to hard but you likely will have to let go of your morals and enter the slimy world of the dirty markets.
Thanks
Glad I sold half my MMNFF but still holding 450,000 I still have a feeling about them.
Thanks MallenNV. I have seen this before. The 911 share trade would be a noticeable thing to watch out for.
Are the market makers largely incentivized to collude with each other most of the time or do they sometimes try to fool each other to make more money?
What are the qualifications to become a market maker?
Thanks
Besao, not sure if you know the MM signals. They use these share trades to send signals to all brokers and market makers. They do not want to send emails or any recorded tracable data that can be illegal market manipulation so they instead put in buy and sell orders for specific round figures.
Also know that when you saw 100 trade the other day was not a trade at all but a market transaction that was never filled so they can send the signal 100 to other market makers. Today 300 traded but again it was not a real trade but a quote only. The other day 100 was posted meaning a market maker needed shares and today 300 that means take it down 30% so well see if the stock drops 30% then you will know more about what to look for and how this crooked market works.
When you see 600 then you can worry. I tested this and on some other tickers. I put in orders to sell at 700 and another ticker 777 and BOTH tickers moved up and I sold and made a good profit. Then as soon as the market makes found out it was not another market maker they quickly posted 300 for 3 days straight. fooled them!
1. 100 - I need Shares.
2. 200 - I need Shares badly but do not take the stock down.
3. 300 - Take (or I am taking) the stock down at least 30% so I can load shares.
4. 400 - Keep trading it sideways.
5. 500 - Gap the stock. Gap can be up or down, depending on direction of 500 signal.
6. 505 - I am short on shares
7. 600 - Apply resistance at the ASK to keep the price from increasing.
8. 700 - Move the price up.
9. 777 - Also recognized as a signal to move the price up.
10. 800 - Prepare for an increase in trading volume.
11. 900 - Allow the stock to float and trade freely.
12. 911 - Pending News/Press Release On The Way
13. 1000 - Don't let it run
14. 2100 - Let it run
Besao. if you have $100 laying around, buy DMAN (demand brands) they have low float, and not to much debt but like always, you never know. But it could be another 40% hit. 2023 DTC shows only 500,000,000 but the 248,000,000 float data is 2021.
They may try an aggressive pump to move them up so get in and and be ready to get out. Just like MMNFF. I'm into DMAN for $.0006 so I am already up but watching them carefully.
Beaso, 40% when have you ever head that was made on the OTC? Glad you MADE money. I'm holding my other 50%. The shares are just too cheap with to much upside. I would not buy at $.0001 and hold for $.0002 with SGMD, 1000's of holders with billions of shares will be doing the same and the market makers will not load up on garbage they cannot resell.
If you like many want to turn $100 into $200 by buying 1,000,000 shares for $100 keep in mind that with 10 billion in the float +- there would be 10,000 investors trying to do the same and the market makers will not buy them all.
Besides the market makers get debt shares for much less then the bid sellers so level two will keep everyone at a loss. You can take the position and say, its only $100 but when you say that 50,000 others say that and 50,000 x $100 is $5,000,000 more paid to debt holders not to retailers selling on the bid.
This is not the stock market, it’s the manipulation debt market, once you understand it and learn how to play the game that is when you will WIN on others LOSSES. It’s the sad truth.
A question about SGMD.. If i put in a GTC order to buy at $0.0001 and also a GTC order to sell at $0.0002 can I repetitively buy at the low and sell at the high doubling my money with each trade? If it were possible everybody would do it as it seems too good to be true.
I got out of MMNFF as the trend upwards has paused. I had around a 40% gain in about two weeks time. The losses seem overwhelming. TLRY is not allowed to own shares. Wouldn’t the future cannabis success stories be the companies the gather up the distressed assets at bargain prices in bankruptcy and then go on to have sizable sales with no debt? The massive debts do no good.
Thanks for your tip.
With such a low daily volume of trading how do the savvy shorts sell massive amounts of shares at say $1.93? You said yourself that once someone tries to sell TREN that the pps would tumble. Thanks
Tren level 2 is only 100 shares and after the 100 smokescreen NOTHING! I think they are doing the paper work to set up the debt dilution! MONEY MONEY here I come!!!!
Smoke and Mirrors my friend. Only 100 shares traded to give you that false data as if the stock is taking off.
When stock start to become stale before the dilution the company associates will buy $100 worth knowing no one will look at the volume trying to fool people into thinking they missed the boat.
Also they do that to move the shares UP higher before the debt dilution so when the stock tanks, investors can say what if it goes back to $1.92 and they buy more cheap diluted shares.
If a pump and dump started at $.01 and the priced dropped people won’t think it can go hither so they move the shares UP higher knowing people will buy more cheap shares thinking they will make that much more when it goes BACK to $1.92
The bid is only $1.18; if someone sells even one share the posted price will drop in half.
MJ
Cannabis is HERE TO STAY! It’s the pump and dump scams that are in free fall that is also passing that decline to legitimate cannabis companies. When the smoke clears cannabis companies will survive that are operational while the scams are cleared out.
TREN is really moving up today. Are you going to cover your short position?
TLRY seems to be in a death spiral as it has convertible debt financing. Almost all cannabis stocks are in free fall at this time.
TLRY cannot really bail out MMNFF when they are so weak themselves it seems.
Thanks
This is a reference to what Tilray owns by Cheebacara at YF MMNFF board. It is said Tilray is not allowed to own shares.
“You know that’s a lie, they bought senior secured debt from Gotham Green that’s rapidly becoming worthless. TLRY can’t own any of Medmen and stay on NASDAQ. See B, that’s why I’m here, without me there would only be shill lies on this board.Do your DD people.
Tilray could eliminate debt, they have some cash but still we don't know what goes on behind closed doors. I don’t know who owns MMNFF debt or at what price point. I looked at data but did not really search debt holders in the filings but ill look today unless you know.
Debt holders may be into the warrant for more then $.03 and if that is the case they would be selling at a loss. If they do the typical give the MMNFF CEO money on 3rd party debt reduction and the CEO issues them LOTS of shares then it would look like the typical pump and dump.
One other thing to look at that I have seen happen first hand. A company I know raised capital but they knew CMGI was going to buy them out and do a stock swap. But CMGI was if I recall (It’s been decades) was at $5.00 per share. The company being bought out figured just sell what ever they can at any price because they knew the shares would be cancelled and CMGI would issue CMGI shares (is CMGI even in business any more?)
I think they sold millions cheap and when CMGI did the merger they issued one shares of CMGI at $5 for LOTS of the private company shares and then CMGI tanked to I believe $.10. That means for every $5 you invested in the private company you got back $.10. If MMNFF does know Tilray will buy them out and cancel the shares, they could just dump billions cheap knowing a stock swap will happen. If Tilray goes UP we make money, it Tilray goes down we lose money.
Of course that is contingent if MMNFF is going to fold the ticker or let Tilray buy it then merge it and cancel the ticker and swap stocks. If it were me as CEO of Tilray I would use my company assets and capital to make MMNFF expand to all states that legalized marijuana since MMNFF has all the certificates in place.
If I was MMNFF and know Tilray was going to buy MMNFF out I guess the CEO would just dump shares for exit strategy money and not care about shareholders. MMNFF CEO can just say they were voted out and Tilray took over so any issues call Tilray. That of course depends on if the CEO was not going with the MMNFF to Tilray.
If I were Tilray I would rather make the MMNFF shares rise back to $.50 from $.03 knowing if it did that I would be able to sell millions of shares for millions of dollars and expand. It’s obvious the MMNFF shares can rise up 1000% from $.03 to $.30 before Tilray will see $19 as quickly if even ever. If Tilray had 1,000,000 Tilray shares to sell for capital they are worth about $2,000,000, if they have 200,000,000 MMNFF and they rise to even $.10 they have $20,000,000 ($18 million more then their stock).
If MMNFF goes to $.50 they have $100,000,000. And I am sure MMNFF will rise up 1000% to $.30 or even $.50 before Tilray hits $19. If I were Tilray I would not toss that capital away so fast and work to make MMNFF rise and have that be easier then to try and move Tilray to $19 per share. I guess we have to just wait and see.
I know what I would do but also MMNFF and Tilray knows that many who are jumping in now at $.03 will crate mass sell offs when the stock rises creating more sellers then buyers and cause the shares to drop. Also many own MMNFF at well above $1.00 who never cost averaged down so they would have to wait and the few getting in now will be the big winners.
Since the toxic convertible debt holders want a lower price to convert their debt shares, doesn’t that fact put powerful downward pressure on the share price of MMNFF?
If the price were to drop to $0.005 would the conversions be 5X or 7 billion new outstanding shares of MMNFF instead of the 1.4 billion shares noted by the quoted bearish investor?
Could Tilray eliminate this toxic debt?
Thanks
I saw much of what you posted and decided to cash out half my shares for what I paid. I bought 900,000 shares for $.0143 for about $13,000 then after seeing the debt convertible notes that also got me thinking to maybe just dump half what I own for the same $13,000 so I now hold 450,000 and got all my investment back. Plus the buy in was short profits but profits is still money so I just decided to back out of half so I am still good with 450,000 at no cost.
Those other tickers I posted that would tank TMC, FUUFF, and TREN, I made some decent profits on those shorts but still waiting for TREN to drop below $1.10. TREN went up on the high priced pump and soon the debt dilution to $.50 so ill make about $2,500 on that ticker as well. It’s all too predictable. It’s like taking candy from a baby. You got into MMNFF at $.018? But that’s ok; you will probably double your money soon also. I still have some feeling this MMNFF is not over yet. They may be down but not out like those other marijuana scams with nothing but BS.
We at least can see MedMen is real. Many other companies with the same writing on the wall managed to turn around and with so many buying dope and MMNFF with real stores and cultivation, they are well ahead of the scams by far, and even though they are having issues, they have too much to lose other then just dumping shares and folding the company.
But you never know.
Tilray had gone to 300 intraday several years ago. It is down 22% today to 1.86. They are said to own 10% of MMNFF at this time.
A poster on Yahoo Finance summarized some key factors about the financials for MMNFF. There is currently $7.6 million cash on hand. Current liabilities are $44 million. There was a $31.2 million net loss in the past year. This rate of loss is accelerating.
There are currently 1.34 billion outstanding shares. There are 1.4 billion convertible debt shares waiting to list. That means a 52% reduction in share value due to future guaranteed dilution.
There are pending lawsuits.
I am not intending to be negative or disparaging. However just simply looking at fundamental financial measures it seems that caution would be advised. All this arguably might already be reflected in the price of MMNFF being down from a high of $7.00 to now around 2.5 cents.
Thanks. The doubling from 1.4 to 3 cents shows some sort of optimism. That was a timely call to buy.
Tilray has lots of cash on hand and I think they may try and buy 100% of MedMen. But I wonder if they want to own two public companies and could elect to swap stocks with MedMen like they did with HEXO.
Like MedMen, Tilray stock is cheap at $1.89 when is used to be $25 3 years ago. MedMen has certifications in place for all US states so any change in legalization and they will likely be the first to get into those markets and have an easy time finding lenders knowing they will be a good risk. And if mushrooms were legalized they would also be one of the first to get certification, but won’t hold my breath.
Changing names on those certifications may cause Tilray to have to re-file under the new name and get re-certified but not sure. It would be easier to just leave MedMen as is for a while even if they did acquire control of MedMen. I am sure many pump and dumps will emerge soon as mushroom stocks and take away investors from MedMen. But MedMen is so cheap right now it may pay for investors to take positions in many tickers.
Also any new mushroom pump and dump will start the shares much higher like all pump and dumps do that will market heavily at $1 or more in the beginning before they add all the debt thru affiliates or subsidiaries. So that takes time and in that time well either see the MedMen deal happen or not and also monitor the shares price.
Only a few will jump in on mushroom scams at $1 or more as they start out with 100,000,000 in the float and dump 500,000,000 or more short that will be covered as soon as they add debt and increase the authorized to 20 billion or more.
That would end up dropping the shares even below MedMen at $.03. We have to also watch the filings of MedMen to make sure they are also not setting up to debt dilute but at $.03 they really don’t have much room to make much like others tickers that dump shares at $.50 or more before they drop to $.03 or less.
If they do a stock swap you would get 1 share of Tilray for every 63 you own in MedMen at $.03. Even though Tilray is down ($1.89 per share) If MedMed could hang on with the new funding and debt reduction and rise to even $.09 would mean Tilray would have to rise from $1.89 to $5.67 and I believe MedMed has a better chance of that then TIlray.
I just don’t know what Tilray or MedMen is up to but ill poke around some more and see what I can find internally. I think Tilray is more interested in getting their stock up then to use the MedMen deal to get MedMen shares up. A guess but maybe not.
But you never know. Tilray going from $2 to $20 is a 10 times gain. MedMen going from $.03 back to even $1 is 33 times gain and at $5 is 166 times gain. I think it will be more likely MedMen will rise with higher gains then to see Tilray go back to $20.
Once you get past $.25 per share with any ticker, You lose 75% of low level retail investors who see it as to expensive and gravitate to the $.00 stocks hoping for a major score. But if the shares rally, more of the investors who paid $5 or more will jump in. Tilray may also see the MedMen stock as a cash cow.
If they do move into the markets with more and more locations and expansion and debt reduction and move MedMen shares back to $1 or more, Tilray would then have enough shares in MedMen to sell and totally eliminate all debt. So they may keep MedMen public but still not 100% sure. Maybe keep MedMen as a subsidiary company.
If Tilray keeps MedMen public as it is now and does expand into more states and reduces debt, they may find that they can make more money with the MedMen stock and company sales then their own and just leave MedMen as it is now.
Tilray says they do $210 million annually. To make $210 million with MedMen with only one store in each state, each store would have to do $4,200,000. If they opened 3 stores per state, each store would only have to do $1.4 million that seems to be easy based on the market. Leaving MedMen public (No stock swap) and planning the expansion could send MedMen back to $1 or more and Tilray would then maybe seriously think about merging Tilray into MedMen but well have to wait and see.
Besao, no, Jimmy did not break any laws. People say yes he did when he did no such thing. If he did, the SEC would open a case. So anyone saying he will pay is delusional! People are not mad they lost $500, they are mad because they believed the shares at $.01 (50,000 shares) would rise to $5 on NASDAQ making them $250,000. They blame Jimmy they lost $250,000 not just $500.
Also the roller coaster with MMNFF! I LOVE IT!
As for SGMD, no lawyer will take the SGMD case on contingency and also retailers would instead just dump money into another scam ticker before paying for an attorney to win back nothing. Plus SGMD has no money or assets to take even if a court case was won. You cannot win when SGMD has the disclaimers on their side. I cannot say it enough times over and over. All these disclaimers protect schemes that never pay out or make investors any money, and no one can sue, plain and simple.
Well you can sue, you just won’t win.
Buying an OTC pump ticker is like going to a yard sale and buying a bicycle and the owner says you have to sign a contract that the seller is not responsible for any damages or injury.
You sign the contract (Same as buying SGMD with the disclaimers as the contract). You take the bike to the local bar and get drunk then ride home, pass out on the bike and fall causing injury and damaging the bike.
Then you tell the seller you were injured and the bike ruined and want you money back for the bike and want the seller to pay your medical bills. You call the police or attorney and they say sorry your fault. Buying a pump and dump stock that fails is also the investors fault for the damage to their bank accounts.
Think of it like this at the same yard sale. What if the buyer said you could fall if you get drunk and hurt yourself and damage the bike (Same as SGMD disclaimers) and you say OK ill just be careful and not drink and ride. Then you go out and do the opposite. When you buy into a pump stock’s structure and news that it could be a winner is the same as drinking the booze. Then when you do buy the stock is like getting on the bike drunk and crash.
Pumped news, then buying diluted shares that decline in price.
Buying a bike then get drunk causing damage with no legal recourse.
Both are the buyer’s fault, Stock or a bike.
Did Jimmy Chan break any laws? Does he personally get to keep prime California land and other assets?
MallenNV has detailed the textbook scam that is SGMD for us whereby letters of intent get written and signed but no actual real attempts at execution ever materialize.
The shorts are insiders in the know that never need to have any concern that they might possibly see a short squeeze.
Is there enough money involved here to interest a securities fraud attorney to get involved in a lawsuit about gaining justice for SGMD shareholders?
Can a clawback of the short insider winnings ever happen?
Thanks
What I am saying is: Since they are already in the controlled and taxed marijuana environment and mushrooms may soon be legalized under the same standards as marijuana (more or less) they have 95% of the hard part done. Facilities, compliance and licensed to sell weed.
My guess is it’s similar to a liquor store that sells only liquor then they file to sell beer and double their sales so it should not be that hard for MMNFF to do since they are up and running and in the dope space already.
If they only have to do some slight regulations to sell mushrooms vs. some scam pump and dump saying they will, may or intend (All means they won’t) enter the $100 billion dollar mushroom space and open stores like YOU KNOW WHO SAID! Or so they pumped.
You can see MMNFF has the real shot at being able to lead that new market for mushrooms.
MedMen has so far done what all others MJ pump and dumps claimed they will do that never did. Next all those pump and dumps will say they are moving into the mushroom space and buy land, grow them sell them for $100 bazillion dollars and never make one penny.
MedMed is up and running in the space so I am taking a shot at what is proven vs. intent. But you never know, one day they can fold or go bankrupt but at least they are holding on and opening more stores and selling under performing stores.
If they cut the fat and thin out costs they may just make it. At $.014 per share buy in for me, it is worth the risk. And I keep digging to see what’s on the inside not like the sugar coated pump and dumps that sell investors a frosted cake that is made of Styrofoam underneath.
I thought that MMNFF was specialized in cannabis products. Do you know that they have an interest and an expertise in psychedelic mushrooms. Like you said in your previous message, this in a newly exciting and also already experimentally proven group of efficacious natural substances for mental health treatment. Psilocybin is the main active molecule to my understanding.
Society is becoming ever more stressful and dystopian, especially for people who are not wealthy. There will need to be a healthy way to treat anxiety and depression. Cannabis is truly great. However psychoactive mushrooms might be an even better medicine for deeper levels of introspection of what it is that might bother a person or distress them. What happens is called meta cognition where the prefrontal cortex sees aspects of how the less executive levels of brain activity are functioning or perhaps in a state of dysfunction.
Besao, 35,000 shares on level 2! 10k, 10k 10k 5k then onto $.54 I said $.50 you will have to excuse me, I was $.04 off. But we also know the market will sell 10k on level two and replace it with more of the same before we hit $.54 but that is usually on a pump and dump that shows 1,000,000 on level 2. I have a feeling and looking at data and what’s happening behind the scenes to see if I can turn my confidence from 80% to 99%.
Beseao, Here is what I am thinking....
My gut tells me that we are very close to having the mushrooms legalized. I am sure 100’s of pump and dumps will switch to a scam to sell shares in mushrooms they will never even get approved to sell let alone even have a facility.
IF MMNFF that has the facilities, the licenses to sell and the established markets, we could see this stock move well. Some MJ facilities are already selling the mushrooms. If MedMed gets ahead of the fake scams it will be a very Merry Christmas!
I am looking into investors and data that are buying MedMen stock so see if they are in the cultivation business and could supply MedMen with inventory.
If suppliers or cultivators are buying MMFFF shares knowing it can rise back to previous highs that would indicate something big is going to happen.
I still don’t like the share structure so I am watching that as well, very carefully.
You are an independent thinker. That is admirable.
MMNFF is performing well. Tilray must have seen something that they liked. Tilray would also want to see the toxic debt situation cleaned up. You say however that you hate the share structure. Will Tilray help to eliminate the debt problem for MMNFF?
Cannabis might be the best product that humans have ever discovered. The benefits seem to far exceed it’s dangers. Independent thinking is a virtue and cannabis seems to promote new ways of thinking about and perceiving the world that we live in.
ALSO Besao, I do not do what I am told. I do things far different.
Shareholder's Money is used for (jimmy Chans all lowercase) personal gain; call the SEC, FINRA, and OTC Markets.
https://budcars.com
Flat line ____________
Followers
|
480
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
53182
|
Created
|
08/11/06
|
Type
|
Free
|
Moderators |
Email: info@sugarmade.com Phone: (626) 346-9512
OTC MARKETS - QUICK LINKS
QUOTE
NEWS
DISCLOSURE
SECURITY DETAILS
SEC (EDGAR) - (OTCQB:SQMD) FILINGS
SEC FILINGS
On January 23, 2019 Sugarmade, Inc. (the “Company”) announced the signing of a Letter of Intent (the “LOI”) to acquire a retail location of Washington State-based Hydro4Less. The LOI outlines the general terms of a possible acquisition transaction. Pending the signing of a definitive agreement, Sugarmade will issue Five Million Dollars ($5,000,000) of its common shares at a price pegged at Ten Cents ($0.10) to the owners of Hydro4Less in exchange for the single retail operation, not including inventories on hand.
Additionally, via the pending transaction, Sugarmade will gain an option, at an acquisition price to be determined later, to purchase two additional Hydro4Less retail operations, which are currently producing in excess of Twenty Million Dollars ($20,000,000) annually. The single location acquisition that is the subject of the LOI, is expected to produce approximately Five Million Dollars ($5,000,000) for calendar year 2019 and is currently operating at a profit with positive operating cash flow. The Company believes the single location the acquisition would be accretive to earning for Sugarmade. Should all three acquisitions close, Sugarmade will increase its annual revenues by approximately Twenty Five Million Dollars ($25,000,000) million per year.
Hydro4Less is significant supplier to the growing hydroponic cultivation sector. Neither the Company nor Hydro4Less conduct any business involving the sale of any cannabis product or relating to any products containing cannabis.
BUDLIFE CANNABIS STORAGE
World's First And Only Patented Storage For Preserving Cannabis Flowers. Maximizing the Power of Medical Cannabis.
SUMMARY - Sugarmade, Inc. (OTCQB:SGMD) plans a leadership role in the market for cannabis storage via introduction of patented storage containers that utilize modified intelligent atmosphere packaging to extend the life of cannabis, preserve terpenes and THC/CBC levels, prevent spoilage, and reduce dangerous pathogens.
Authorized Shares | 1,990,000,000 | 12/31/2018 | |
Outstanding Shares | 646,888,318 | 12/31/2018 | |
-Restricted | 454,296,711 | 12/31/2018 | |
-Unrestricted | 192,591,607 | 12/31/2018 | |
Held at DTC | 184,493,775 | 12/31/2018 | |
| Float | 190,091,607 | 12/27/2018 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |